Metabolism and obesity are the focus of a major research initiative by the University of Gothenburg and AstraZeneca, with the ...

Metabolism and obesity are the focus of a major research initiative by the University of Gothenburg and AstraZeneca, with the ...

NodThera Announces Appointment of Elisabeth Björk as Board Member Former SVP at AstraZeneca R&D brings deep expertise in ...

Day One officially began on Monday, June 15, 2025, with an automation session chaired by LCGC International’s Pharmaceutical Perspectives columnist, and active member of ChromSoc, Adrian Clarke from ...

ABU DHABI, 3rd June, 2025 (WAM) -- M42, a global health leader powered by technology, announced a strategic collaboration with AstraZeneca and SOPHiA GENETICS to bring cutting-edge liquid biopsy ...

A fixed-duration regimen of AstraZeneca’s Calquence (acalabrutinib) in combination with venetoclax, with or without obinutuzumab, has been approved in the European Union (EU) for the treatment of ...

SALT LAKE CITY — The pharmaceutical drug company AstraZeneca filed a lawsuit against the Utah attorney general, claiming Utah's new law on limiting prescription drug prices goes against a ...

SALT LAKE CITY (ABC4) — The pharmaceutical company AstraZeneca has filed a federal lawsuit against Utah Attorney General Derek Brown and Utah Insurance Commissioner Jon Pike over a recent law that is ...

Vickers was right. AstraZeneca, the global pharmaceutical company that generated more than $54 billion in revenue in 2024, is now suing Utah Attorney General Derek Brown and Utah Insurance ...

Pharmaceutical giant AstraZeneca is suing Utah’s attorney general and insurance commissioner over a law passed during the legislative session aimed at stopping drug manufacturers from limiting ...